Sfoglia per Rivista
FIRST-LINE TREATMENT CHOICE FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: WHAT DO CLINICIANS CARE ABOUT? THE CLL FITNESS STUDY
2014-01-01 Scarfo, L; Quaresmini, G; Ambrosetti, A; Laurenti, L; Rossini, F; Trentin, L; Coscia, Marta; Orlandi, E; Mannina, D; Torreggiani, A; Rambaldi, A; Semenzato, G; Innocenti, I; Brugiatelli, M; Cuneo, A; Foa, R; Molica, S; Morra, E; Pane, F; Pizzolo, G; Ghia, P.
Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms.
2011-01-01 Elena, C; Rumi, E; Portolan, M; Della Porta, Mg; Pascutto, C; Passamonti, Francesco
Frequency and function of regulatory T cells (Tregs) are highly preserved in multiple myeloma
2006-01-01 Foglietta, Myriam; Mariani, Sara; Castella, Barbara; Coscia, Marta; Boccadoro, Mario; Massaia, Massimo
FRONT-LINE THERAPY WITH FLUDARABINE, CYCLOPHOSPHAMIDE, OFATUMUMAB (FC-O2) IN YOUNG (<= 65 YRS) AND FIT CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS. RESULTS OF THE PROSPECTIVE PHASE 2 GIMEMA STUDY LLC0911
2017-01-01 Mauro, Fr; Molica, S; Zaja, F; Piciocchi, A; Ilariucci, F; Coscia, M; Carella, Am; Re, F; Liberati, Am; Tedeschi, A; Gozzetti, A; Cuneo, A; Cortelezzi, A; Baraldi, A; Del Poeta, G; Musolino, C; Battistini, R; De Propris, Ms; Della Starza, I; Raponi, S; Ilari, C; Cafforio, L; Nanni, M; Fazi, P; Vignetti, M; Russo, F; Porrazzo, M; Riemma, C; Specchia, G; Neri, A; Guarini, A; Foa, R
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia
2020-01-01 Griggio, Valentina; Vitale, Candida; Todaro, Maria; Riganti, Chiara; Kopecka, Joanna; Salvetti, Chiara; Bomben, Riccardo; Dal Bo, Michele; Magliulo, Daniela; Rossi, Davide; Pozzato, Gabriele; Bonello, Lisa; Marchetti, Monia; Omedè, Paola; Kodipad, Ahad Ahmed; Laurenti, Luca; Del Poeta, Giovanni; Mauro, Francesca Romana; Bernardi, Rosa; Zenz, Thorsten; Gattei, Valter; Gaidano, Gianluca; Foà, Robin; Massaia, Massimo; Boccadoro, Mario; Coscia, Marta
High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2)
2020-01-01 Mauro, F. R.; Molica, S.; Soddu, S.; Ilariucci, F.; Coscia, M.; Zaja, F.; Angelucci, E.; Re, F.; Liberati, A. M.; Tedeschi, A.; Reda, G.; Pietrasanta, D.; Gozzetti, A.; Battistini, R.; Del Poeta, G.; Musolino, C.; Nanni, M.; Piciocchi, A.; Vignetti, M.; Neri, A.; Albano, F.; Cuneo, A.; Giudice, I. D.; Starza, I. D.; de Propris, M. S.; Raponi, S.; Guarini, A. R.; Foa, R.
Higher adherence to the Mediterranean diet is associated with lower levels of D-dimer: findings from the MOLI-SANI study.
2017-01-01 Di Castelnuovo, A; Bonaccio, M; De Curtis, A; Costanzo, S; Persichillo, M; de Gaetano, G; Donati, Mb; Iacoviello, Licia; MOLI SANI, Investigators
HLA-G is a component of the CLL escape repertoire to generate immune suppression: impact of HLA-G 14 bp (rs66554220) polymorphism
2014-01-01 R., Rizzo; Audrito, Valentina; P., Vacca; D., Rossi; Brusa, Davide; M., Stignani; D., Bortolotti; G., D' Arena; Coscia, Marta; L., Laurenti; F., Forconi; G., Gaidano; M. C., Mingari; L., Moretta; Malavasi, Fabio; Deaglio, Silvia
Home-treatment of deep vein thrombosis in patients with cancer
2005-01-01 Ageno, Walter; Grimwood, R; Limbiati, S; Dentali, Francesco; Steidl, L; Wells, Ps
How we changed our approach to venous thromboembolism
2022-01-01 Ageno, Walter
Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia
2011-01-01 Griggio, Valentina; Capello, Michela; Linty, F; Vitale, Candida; Peola, S; Cappello, Paola; Castella, Barbara; Rigoni, MICOL MARIA; Sciancalepore, Patrizia; Drandi, Daniela; Ruggeri, Marina; Omedè, P; Ladetto, Marco; Novelli, Francesco; Boccadoro, Mario; Massaia, Massimo; Coscia, Marta
IGHV UNMUTATED CLL B CELLS ARE MORE PRONE TO SPONTANEOUS APOPTOSIS AND DEPEND FROM THE ANTI-APOPTOTIC EFFECT OF ENVIRONMENTAL SIGNALS
2011-01-01 Coscia, Marta; Pantaleoni, Francesca; Riganti, Chiara; Vitale, Candida; Rigoni, MICOL MARIA; Silvia, Peola; Drandi, Daniela; Ladetto, Marco; Ruggeri, Marina; Griggio, Valentina; Castella, Barbara; Sciancalepore, Patrizia; Paola, Omedè; Bosia, Amalia; Boccadoro, Mario; Massaia, Massimo
IGHV1-69/D3-16/J3 SUBSET 6 IS ASSOCIATED WITH INDOLENT DISEASE COURSE OF EARLY STAGE CLL (RAI 0) INDEPENDENT OF UNMUTATED STATUS
2010-01-01 F., Forconi; E., Cencini; D., Rossi; E., Sozzi; R., Bomben; R., Marasca; Coscia, Marta; Massaia, Massimo; S., Veronese; A., Tedeschi; M., Montillo; R., Fazzi; M., Petrini; S., Ciolli; A., Bosi; R., Dottori; M., Pirrotta; A., Caremani; G., Del Poeta; I., Del Giudice; S., Santangelo; L., Laurenti; D., Efremov; L., Trentin; F., Bertoni; V., Gattei; G., Gaidano; F., Lauria
Immunoglobulin variable heavy-chain (Ig Vh) mutational status and tumor microenvironment interactions in B-cell chronic lymphocytic leukaemia
2007-01-01 Pantaleoni, Francesca; Coscia, Marta; Bussolati, Benedetta; Deambrosis, Ilaria; Peola, S; Rigoni, MICOL MARIA; Boccadoro, Mario; Camussi, Giovanni; Massaia, Massimo
Immunophenotypic profile and cytogenetic aberrations detected by interphase FISH in B-CLL patients
2011-01-01 Ruggeri, Marina; Caltagirone, Simona Angela; Gilestro, M; Aschero, Simona; Astolfi, Monica; Oddolo, D; Saraci, E; Muccio, Ve; Bergui, L; Coscia, Marta; Omedè, P; Boccadoro, Mario
IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS
2011-01-01 Coscia, Marta; Rigoni, MICOL MARIA; Riganti, Chiara; Campia, Ivana; Vitale, Candida; Silvia, Peola; Castella, Barbara; Griggio, Valentina; Pantaleoni, Francesca; Sciancalepore, Patrizia; Drandi, Daniela; Ladetto, Marco; Bosia, Amalia; Boccadoro, Mario; Massaia, Massimo
IN ADULT ACUTE MYELOID LEUKAEMIA (AML) ALL RISK SUBSETS BENEFIT FROM A SEQUENTIAL HIGH-DOSE PROGRAMME AS EARLY RESCUE OF FIRST INDUCTION FAILURE: A REPORT FROM NORTHERN ITALY LEUKAEMIA GROUP (NILG)
2010-01-01 Intermesoli, T; Rossi, G; Pogliani, E; Marmont, F; Cavattoni, I; Cassibba, V; Scattolin, A; Musso, M; Mattei, D; Minotto, C; Ciceri, F; Campiotti, L; Corradini, P; Borlenghi, E; Ruggeri, G; Terruzzi, E; Verga, L; Audisio, E; Fabris, P; Chisesi, T; Giussani, U; Spinelli, O; Zanghi, P; Oldani, E; Barbui, T; Rambaldi, A; Bassan, R
Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients.
2011-01-01 Rumi, E; Passamonti, Francesco; Elena, C; Pietra, D; Arcaini, L; Astori, C; Zibellini, S; Boveri, E; Pascutto, C; Lazzarino, M.
Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease.
2003-01-01 Vohnout, B; Di Castelnuovo, A; Trotta, R; D'Orazi, A; Panniteri, G; Montali, A; Donati, Mb; Arca, M; Iacoviello, Licia
Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome
2022-01-01 Giarretta, I.; Ageno, W.; Dentali, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| FIRST-LINE TREATMENT CHOICE FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: WHAT DO CLINICIANS CARE ABOUT? THE CLL FITNESS STUDY | 1-gen-2014 | Scarfo, L; Quaresmini, G; Ambrosetti, A; Laurenti, L; Rossini, F; Trentin, L; Coscia, Marta; Orlandi, E; Mannina, D; Torreggiani, A; Rambaldi, A; Semenzato, G; Innocenti, I; Brugiatelli, M; Cuneo, A; Foa, R; Molica, S; Morra, E; Pane, F; Pizzolo, G; Ghia, P. | |
| Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms. | 1-gen-2011 | Elena, C; Rumi, E; Portolan, M; Della Porta, Mg; Pascutto, C; Passamonti, Francesco | |
| Frequency and function of regulatory T cells (Tregs) are highly preserved in multiple myeloma | 1-gen-2006 | Foglietta, Myriam; Mariani, Sara; Castella, Barbara; Coscia, Marta; Boccadoro, Mario; Massaia, Massimo | |
| FRONT-LINE THERAPY WITH FLUDARABINE, CYCLOPHOSPHAMIDE, OFATUMUMAB (FC-O2) IN YOUNG (<= 65 YRS) AND FIT CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS. RESULTS OF THE PROSPECTIVE PHASE 2 GIMEMA STUDY LLC0911 | 1-gen-2017 | Mauro, Fr; Molica, S; Zaja, F; Piciocchi, A; Ilariucci, F; Coscia, M; Carella, Am; Re, F; Liberati, Am; Tedeschi, A; Gozzetti, A; Cuneo, A; Cortelezzi, A; Baraldi, A; Del Poeta, G; Musolino, C; Battistini, R; De Propris, Ms; Della Starza, I; Raponi, S; Ilari, C; Cafforio, L; Nanni, M; Fazi, P; Vignetti, M; Russo, F; Porrazzo, M; Riemma, C; Specchia, G; Neri, A; Guarini, A; Foa, R | |
| HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia | 1-gen-2020 | Griggio, Valentina; Vitale, Candida; Todaro, Maria; Riganti, Chiara; Kopecka, Joanna; Salvetti, Chiara; Bomben, Riccardo; Dal Bo, Michele; Magliulo, Daniela; Rossi, Davide; Pozzato, Gabriele; Bonello, Lisa; Marchetti, Monia; Omedè, Paola; Kodipad, Ahad Ahmed; Laurenti, Luca; Del Poeta, Giovanni; Mauro, Francesca Romana; Bernardi, Rosa; Zenz, Thorsten; Gattei, Valter; Gaidano, Gianluca; Foà, Robin; Massaia, Massimo; Boccadoro, Mario; Coscia, Marta | |
| High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2) | 1-gen-2020 | Mauro, F. R.; Molica, S.; Soddu, S.; Ilariucci, F.; Coscia, M.; Zaja, F.; Angelucci, E.; Re, F.; Liberati, A. M.; Tedeschi, A.; Reda, G.; Pietrasanta, D.; Gozzetti, A.; Battistini, R.; Del Poeta, G.; Musolino, C.; Nanni, M.; Piciocchi, A.; Vignetti, M.; Neri, A.; Albano, F.; Cuneo, A.; Giudice, I. D.; Starza, I. D.; de Propris, M. S.; Raponi, S.; Guarini, A. R.; Foa, R. | |
| Higher adherence to the Mediterranean diet is associated with lower levels of D-dimer: findings from the MOLI-SANI study. | 1-gen-2017 | Di Castelnuovo, A; Bonaccio, M; De Curtis, A; Costanzo, S; Persichillo, M; de Gaetano, G; Donati, Mb; Iacoviello, Licia; MOLI SANI, Investigators | |
| HLA-G is a component of the CLL escape repertoire to generate immune suppression: impact of HLA-G 14 bp (rs66554220) polymorphism | 1-gen-2014 | R., Rizzo; Audrito, Valentina; P., Vacca; D., Rossi; Brusa, Davide; M., Stignani; D., Bortolotti; G., D' Arena; Coscia, Marta; L., Laurenti; F., Forconi; G., Gaidano; M. C., Mingari; L., Moretta; Malavasi, Fabio; Deaglio, Silvia | |
| Home-treatment of deep vein thrombosis in patients with cancer | 1-gen-2005 | Ageno, Walter; Grimwood, R; Limbiati, S; Dentali, Francesco; Steidl, L; Wells, Ps | |
| How we changed our approach to venous thromboembolism | 1-gen-2022 | Ageno, Walter | |
| Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia | 1-gen-2011 | Griggio, Valentina; Capello, Michela; Linty, F; Vitale, Candida; Peola, S; Cappello, Paola; Castella, Barbara; Rigoni, MICOL MARIA; Sciancalepore, Patrizia; Drandi, Daniela; Ruggeri, Marina; Omedè, P; Ladetto, Marco; Novelli, Francesco; Boccadoro, Mario; Massaia, Massimo; Coscia, Marta | |
| IGHV UNMUTATED CLL B CELLS ARE MORE PRONE TO SPONTANEOUS APOPTOSIS AND DEPEND FROM THE ANTI-APOPTOTIC EFFECT OF ENVIRONMENTAL SIGNALS | 1-gen-2011 | Coscia, Marta; Pantaleoni, Francesca; Riganti, Chiara; Vitale, Candida; Rigoni, MICOL MARIA; Silvia, Peola; Drandi, Daniela; Ladetto, Marco; Ruggeri, Marina; Griggio, Valentina; Castella, Barbara; Sciancalepore, Patrizia; Paola, Omedè; Bosia, Amalia; Boccadoro, Mario; Massaia, Massimo | |
| IGHV1-69/D3-16/J3 SUBSET 6 IS ASSOCIATED WITH INDOLENT DISEASE COURSE OF EARLY STAGE CLL (RAI 0) INDEPENDENT OF UNMUTATED STATUS | 1-gen-2010 | F., Forconi; E., Cencini; D., Rossi; E., Sozzi; R., Bomben; R., Marasca; Coscia, Marta; Massaia, Massimo; S., Veronese; A., Tedeschi; M., Montillo; R., Fazzi; M., Petrini; S., Ciolli; A., Bosi; R., Dottori; M., Pirrotta; A., Caremani; G., Del Poeta; I., Del Giudice; S., Santangelo; L., Laurenti; D., Efremov; L., Trentin; F., Bertoni; V., Gattei; G., Gaidano; F., Lauria | |
| Immunoglobulin variable heavy-chain (Ig Vh) mutational status and tumor microenvironment interactions in B-cell chronic lymphocytic leukaemia | 1-gen-2007 | Pantaleoni, Francesca; Coscia, Marta; Bussolati, Benedetta; Deambrosis, Ilaria; Peola, S; Rigoni, MICOL MARIA; Boccadoro, Mario; Camussi, Giovanni; Massaia, Massimo | |
| Immunophenotypic profile and cytogenetic aberrations detected by interphase FISH in B-CLL patients | 1-gen-2011 | Ruggeri, Marina; Caltagirone, Simona Angela; Gilestro, M; Aschero, Simona; Astolfi, Monica; Oddolo, D; Saraci, E; Muccio, Ve; Bergui, L; Coscia, Marta; Omedè, P; Boccadoro, Mario | |
| IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS | 1-gen-2011 | Coscia, Marta; Rigoni, MICOL MARIA; Riganti, Chiara; Campia, Ivana; Vitale, Candida; Silvia, Peola; Castella, Barbara; Griggio, Valentina; Pantaleoni, Francesca; Sciancalepore, Patrizia; Drandi, Daniela; Ladetto, Marco; Bosia, Amalia; Boccadoro, Mario; Massaia, Massimo | |
| IN ADULT ACUTE MYELOID LEUKAEMIA (AML) ALL RISK SUBSETS BENEFIT FROM A SEQUENTIAL HIGH-DOSE PROGRAMME AS EARLY RESCUE OF FIRST INDUCTION FAILURE: A REPORT FROM NORTHERN ITALY LEUKAEMIA GROUP (NILG) | 1-gen-2010 | Intermesoli, T; Rossi, G; Pogliani, E; Marmont, F; Cavattoni, I; Cassibba, V; Scattolin, A; Musso, M; Mattei, D; Minotto, C; Ciceri, F; Campiotti, L; Corradini, P; Borlenghi, E; Ruggeri, G; Terruzzi, E; Verga, L; Audisio, E; Fabris, P; Chisesi, T; Giussani, U; Spinelli, O; Zanghi, P; Oldani, E; Barbui, T; Rambaldi, A; Bassan, R | |
| Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients. | 1-gen-2011 | Rumi, E; Passamonti, Francesco; Elena, C; Pietra, D; Arcaini, L; Astori, C; Zibellini, S; Boveri, E; Pascutto, C; Lazzarino, M. | |
| Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease. | 1-gen-2003 | Vohnout, B; Di Castelnuovo, A; Trotta, R; D'Orazi, A; Panniteri, G; Montali, A; Donati, Mb; Arca, M; Iacoviello, Licia | |
| Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome | 1-gen-2022 | Giarretta, I.; Ageno, W.; Dentali, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile